Boston Scientific Quick Ratio 2006-2019 | BSX

Historical quick ratio values for Boston Scientific (BSX) over the last 10 years.
Boston Scientific Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2019-06-30 $5.03B $4.85B 1.04
2019-03-31 $5.01B $4.48B 1.12
2018-12-31 $2.84B $5.26B 0.54
2018-09-30 $2.84B $5.08B 0.56
2018-06-30 $2.84B $4.75B 0.60
2018-03-31 $2.97B $4.99B 0.60
2017-12-31 $2.74B $5.65B 0.49
2017-09-30 $2.40B $4.83B 0.50
2017-06-30 $2.20B $4.30B 0.51
2017-03-31 $2.06B $3.49B 0.59
2016-12-31 $2.28B $3.59B 0.64
2016-09-30 $2.18B $3.02B 0.72
2016-06-30 $2.35B $3.18B 0.74
2016-03-31 $2.14B $2.61B 0.82
2015-12-31 $2.46B $2.43B 1.01
2015-09-30 $2.38B $2.24B 1.06
2015-06-30 $2.81B $1.94B 1.45
2015-03-31 $2.23B $2.46B 0.91
2014-12-31 $2.66B $2.85B 0.94
2014-09-30 $2.19B $1.82B 1.20
2014-06-30 $2.27B $1.77B 1.28
2014-03-31 $2.01B $1.72B 1.17
2013-12-31 $2.11B $1.82B 1.16
2013-09-30 $2.63B $1.90B 1.38
2013-06-30 $2.66B $2.48B 1.07
2013-03-31 $2.25B $1.64B 1.38
2012-12-31 $2.14B $1.77B 1.21
2012-09-30 $2.26B $1.82B 1.25
2012-06-30 $2.21B $1.79B 1.23
2012-03-31 $2.20B $1.67B 1.32
2011-12-31 $2.17B $1.81B 1.20
2011-09-30 $2.24B $1.89B 1.19
2011-06-30 $2.22B $1.89B 1.17
2011-03-31 $2.67B $2.04B 1.31
2010-12-31 $2.72B $2.61B 1.04
2010-09-30 $2.63B $2.96B 0.89
2010-06-30 $3.10B $3.72B 0.83
2010-03-31 $2.84B $2.91B 0.98
2009-12-31 $3.71B $3.02B 1.23
2009-09-30 $4.02B $3.18B 1.27
2009-06-30 $3.92B $2.75B 1.43
2009-03-31 $3.72B $2.43B 1.53
2008-12-31 $4.60B $3.23B 1.42
2008-09-30 $4.43B $3.54B 1.25
2008-06-30 $4.36B $3.04B 1.44
2008-03-31 $4.46B $3.39B 1.31
2007-12-31 $5.22B $3.25B 1.61
2007-09-30 $3.87B $3.38B 1.15
2007-06-30 $4.10B $2.97B 1.38
2007-03-31 $3.79B $2.37B 1.60
2006-12-31 $5.35B $2.63B 2.03
2006-09-30 $3.99B $2.45B 1.63
2006-06-30 $3.61B $2.17B 1.66
2006-03-31 $2.47B $2.04B 1.21
2005-12-31 $2.21B $1.48B 1.50
2005-09-30 $2.33B $1.14B 2.04
2005-06-30 $2.31B $1.76B 1.31
2005-03-31 $2.37B $1.78B 1.33
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $53.588B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $146.323B 26.71
Medtronic (MDT) Ireland $145.061B 20.36
Stryker (SYK) United States $80.552B 27.85
Baxter (BAX) United States $44.924B 27.24
EssilorLuxottica Societe Anonyme (ESLOY) France $32.865B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.253B 18.08
Coloplast (CLPBY) Denmark $25.488B 40.69
Lonza Group Ag (LZAGY) Switzerland $25.356B 0.00
Terumo (TRUMY) Japan $24.335B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $20.897B 0.00
ResMed (RMD) United States $18.864B 35.95
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.229B 54.83
Insulet (PODD) United States $9.266B 549.07
Perrigo (PRGO) Ireland $7.333B 13.51
Canopy Growth (CGC) Canada $7.030B 0.00
Hill-Rom Holdings (HRC) United States $6.817B 20.33
Haemonetics (HAE) United States $6.460B 48.76
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.786B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.648B 0.00
NuVasive (NUVA) United States $3.463B 27.61
Neogen (NEOG) United States $3.393B 56.77
ICU Medical (ICUI) United States $3.219B 20.88
Quidel (QDEL) United States $2.561B 25.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.550B 0.00
Agios Pharmaceuticals (AGIO) United States $1.943B 0.00
National Vision Holdings (EYE) United States $1.805B 38.97
Cardiovascular Systems (CSII) United States $1.730B 0.00
Aphria (APHA) $1.197B 0.00
VAREX IMAGING (VREX) United States $1.103B 25.42
AtriCure (ATRC) United States $1.057B 0.00
Phibro Animal Health (PAHC) United States $0.853B 13.88
Eagle Pharmaceuticals (EGRX) United States $0.843B 21.50
Omeros (OMER) United States $0.782B 0.00
NanoString Technologies (NSTG) United States $0.760B 0.00
Lantheus Holdings (LNTH) United States $0.732B 19.25
LeMaitre Vascular (LMAT) United States $0.696B 41.24
PetIQ (PETQ) United States $0.676B 15.98
Cerus (CERS) United States $0.627B 0.00
Surmodics (SRDX) United States $0.605B 114.95
MacroGenics (MGNX) United States $0.538B 0.00
Quanterix (QTRX) United States $0.527B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.21
TG Therapeutics (TGTX) United States $0.518B 0.00
Owens & Minor (OMI) United States $0.450B 13.47
Meridian Bioscience (VIVO) United States $0.428B 13.37
Utah Medical Products (UTMD) United States $0.356B 26.11
Zynex (ZYXI) United States $0.340B 36.14
BioLife Solutions (BLFS) United States $0.332B 102.06
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.326B 0.00
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.229B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Repro-Med Systems (REPR) United States $0.163B 0.00
Rockwell Medical (RMTI) United States $0.158B 0.00
Cytosorbents (CTSO) United States $0.146B 0.00
Female Health (VERU) United States $0.140B 0.00
Fonar (FONR) United States $0.130B 9.14
Liberty Health Sciences (LHSIF) Canada $0.106B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
Chimerix (CMRX) United States $0.089B 0.00
United-Guardian (UG) United States $0.085B 20.00
Nephros (NEPH) United States $0.083B 0.00
MTech Acquisition (KERN) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Surface Oncology (SURF) United States $0.037B 0.00
Senestech (SNES) United States $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00